医疗保险对下肢旁路术的报销未能覆盖多数严重肢体缺血患者的治疗成本
本研究评估了严重肢体缺血患者接受下肢旁路术的医院技术成本和专业成本与医疗保险报销的关系。分析68例患者发现,仅最复杂DRG 252的报销可覆盖总成本(中位贡献边际2490美元),而DRG 253和254的中位贡献边际分别为-3100美元和-4902美元。住院时间延长和术前透析与负边际显著相关。
要点
- 多数严重肢体缺血患者下肢旁路术的报销不足以覆盖治疗成本。
- 仅最复杂DRG 252患者的总成本获得 adequate 补偿。
- 住院时间每增加一天和术前透析与负贡献边际显著相关。
核心结论
- 对多数严重肢体缺血患者,现行医疗保险报销不足以覆盖开放旁路术后的治疗成本。
研究设计与样本
- 回顾性分析2011至2017年单中心68例血流动力学确诊的严重肢体缺血接受下肢旁路术的患者,结合医院成本核算系统和血管质量倡议注册数据。
主要发现
- DRG 252中位贡献边际为2490美元(IQR -1621至10080),DRG 253为-3100美元(IQR -8499至109),DRG 254为-4902美元(IQR -9259至1059)。
- 技术成本和专业成本均随DRG复杂度显著变化,但专业报销随DRG复杂度增加无显著变化。
- 多变量模型中,住院时间每增加一天贡献边际减少2547美元,术前透析减少5555美元。
临床怎么用
- 临床需关注严重肢体缺血旁路术的经济可持续性,尤其对DRG 253和254患者及住院时间长、术前透析者。
局限性
- 单中心回顾性研究,样本量68例,非医疗保险患者报销按医疗保险费率指数化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Lower extremity bypass surgery remains an important treatment option for patients with critical limb ischemia (CLI), but is resource intensive. We sought to evaluate the cost and Medicare reimbursement for lower extremity bypass surgery in patients with CLI. METHODS: Hospital cost accounting systems were queried for total technical and professional costs incurred and reimbursement received for patients with CLI undergoing lower extremity bypass at our center between 2011 and 2017. Patients were identified by assignment to Diagnosis-Related Group (DRG) 252, 253, or 254 (other vascular procedure with major complication/comorbidity, with complication/comorbidity, and without complication/comorbidity, respectively). Additional clinical data were incorporated from the Vascular Quality Initiative clinical registry. For non-Medicare patients, reimbursement was indexed to Medicare rates. Contribution margins (reimbursement minus cost) from technical and professional services were analyzed for each patient and summarized by DRG. We compared technical, professional, and total costs; reimbursement; and contribution margins across DRGs using univariate statistics and evaluated factors associated with total contribution margin using median quantile regression. RESULTS: We analyzed 68 patients with hemodynamically confirmed CLI (46% rest pain, 54% tissue loss), of whom 25% received a prosthetic graft. Mean age was 66.1 ± 11.6 years, 69% were male, 49% diabetic, 44% current smokers, and 4% on dialysis. In general, total infrainguinal bypass cost was adequately compensated for patients assigned only the most complex DRG 252 (median, $2490; interquartile range [IQR], -$1,621 to $10,080). In the majority of patients with less complex DRG 253 (median, -$3,100; IQR, -$8499 to $109) and DRG 254 (median, -$4902; IQR, -$9259 to $1059), reimbursement did not cover the cost of care. Both technical costs and professional costs varied significantly with the complexity of DRG. Although reimbursement from technical services increased alongside increasing complexity of DRG, there was insignificant variation in professional reimbursement as DRG complexity increased. On multivariable modeling, longer length of stay (-$2547 per additional day) and preoperative dialysis (-$5555) were significantly associated with negative margins. CONCLUSIONS: For the majority of patients with CLI, current Medicare reimbursement does not adequately cover the cost of providing care after open bypass surgery. As commercial insurers move toward Medicare reimbursement rates, more granular risk stratification profiles are needed to ensure open surgical care for patients with CLI remains financially sustainable.
引用
- Voicu S, Trooboff SW, Goodney PP, et al. Medicare reimbursement of lower extremity bypass does not cover cost of care for most patients with critical limb ischemia. J Vasc Surg. 2020. PMID: 32829764. doi:10.1016/j.jvs.2020.01.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。